The role of β-amyloid protein in synaptic function: Implications for Alzheimer's disease therapy

Current Neuropharmacology

Volumn 4, Issue 2, 2006, Pages 149-163

  Pena F ^a   Gutierrez Lerma A I ^a   Quiroz Baez, R ^b   Arias, C ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

amyloid protein; Alzheimer disease; Cognitive impairment; Synaptic dysfunction; Synaptic plasticity

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID PRECURSOR PROTEIN; ANTILIPEMIC AGENT; BENZOPHENONE DERIVATIVE; BETA SECRETASE; BETA SECRETASE INHIBITOR; CATION CHANNEL; CHOLINESTERASE INHIBITOR; DONEPEZIL; GAMMA SECRETASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; JLK 1 8; L 405 484; L 682 679; L 685 458; L 852 205; L 852 505; L 852 646; NONSTEROID ANTIINFLAMMATORY AGENT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; BIOCHEMISTRY; BRAIN ELECTROPHYSIOLOGY; CHANNEL GATING; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; DISEASE MODEL; ENZYME INHIBITION; GENETIC ANALYSIS; HUMAN; INHIBITION KINETICS; LONG TERM DEPRESSION; MOLECULAR MECHANICS; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SENILE PLAQUE; SYNAPTIC TRANSMISSION;

EID: 33646570823     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015906776359531     Document Type: Review

References (206)

1. Abel, T., Kandel, E. (1998) Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res. Brain Res. Rev., 26, 360-378.
2. Ahrens, K.F., Freeman, W.J. (2001) Response Dynamics of Entorhinal Cortex in Awake, Anesthetized, and Bulbotomized Rats. Brain Res., 911, 193-202.
3. Almeida, C.G., Tampellini, D., Takahashi, R.H., Greengard, P., Lin, M.T., Snyder, E.M., Gouras, G.K. (2005) β-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis., 20, 187-198.
4. Angulo, E., Noe, V., Casado, V., Mallol, J., Gomez-Isla, T., Lluis, C., Ferrer, I., Ciudad, C.J., Franco, R. (2004) Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J. Neurochem., 91, 547-557.
5. Arias, C., Arrieta, I., Tapia, R. (1995) β-amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J. Neurosci. Res., 41, 561-566.
6. Arias, C., Montiel, T., Quiroz-Báez, R., Massieu, L. (2002) β-amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. Exp. Neurol., 176, 163-174.
7. Arispe, N. (2004) Architecture of the Alzheimer's AβP ion channel pore. J. Membr. Biol., 197, 33-48.
8. Arispe, N., Pollard, H.B., Rojas, E. (1993b) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP (1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U.S.A., 90, 10573-10577.
9. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl. Acad. Sci. U.S.A., 93, 1710-1715.
10. Arispe, N., Rojas, E., Pollard, H.B. (1993a) Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A., 90, 567-571.
11. Asai, M., Hattori, C., Szabo, B., Sasagawa, N., Maruyama, K., Tanuma, S., Ishiura, S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase. Biochem. Biophys. Res., 301, 231-235.
12. Asanuma, M., Nishibayashi-Asanuma, S., Miyazaki, I., Kohno, M., Ogawa, N. (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem., 76, 1895-1904.
13. Ashenafi, S., Fuente, A., Criado, J.M., Riolobos, A.S., Heredia, M., Yajeya, J. (2005) β-Amyloid peptide25-35 depresses excitatory synaptic transmission in the rat basolateral amygdala "in vitro". Neurobiol. Aging, 26, 419-428.
14. 2+ channel modulation in the neuroprotective actions of estrogen in β-amyloid protein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models. Neurochem. Int., 45, 31-38.
15. Bard, F., Cannon, C., Barbou, R., Burke, R.L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., Yednock, T. (2000) Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med., 6, 916-919.
16. Bartoo, G.T., Nochlin, D., Chang, D., Kim, Y., Sumi, S.M. (1997) The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease. J. Neuropathol. Exp. Neurol., 56, 531-540.
17. Basar, E., Basar-Eroglu, C., Karakas, S., Schurmann, M. (1999) Are cognitive processes manifested in event-related gamma, alpha, theta and delta oscillations in the EEG? Neurosci. Lett., 259, 165-168.
18. Basar, E., Basar-Eroglu, C., Karakas, S., Schurmann, M. (2000) Brain oscillations in perception and memory. Int. J. Psychophysiol., 35, 95-124.
19. Bell, K.F., de Kort, G.J., Steggerda, S., Shigemoto, R., Ribeiro-daSilva, A., Cuello, A.C. (2003) Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci. Lett., 353, 143-147.
20. Bertoni-Freddari, C., Fattoretti, P., Meier-Ruge, W., Ulrich, J. (1989) Computer-assisted morphometry of synaptic plasticity during aging and dementia. Pathol. Res. Pract., 185, 799-802.
21. Blanchard, B.J., Stockwell, B.R., Ingram, V.M. (2002b) Eliminating membrane depolarization caused by the Alzheimer peptide Aβ(1-42). Biochem. Biophys. Res. Commun., 293, 1204-1208.
22. Blanchard, B.J., Thomas, V.L., Ingram, V.M. (2002a) Mechanism of membrane depolarization caused by the Alzheimer Aβ1-42 peptide. Biochem. Biophys. Res. Commun.,293, 1197-1203.
23. Bliss, T.V., Collingridge, G.L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31-39.
24. Brenowitz, E.A., Baptista, L.F., Lent, K., Wingfield, J.C. (1998) Seasonal plasticity of the song control system in wild Nuttall's white-crowned sparrows. J. Neurobiol., 34, 69-82.
25. Brown, J.T., Richardson, J.C., Collingridge, G.L., Randall, A.D., Davies, C.H. (2005) Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus, 15, 110-117.
26. Brunkan, A.L., Goate, A.M. (2005) Presenilin endoproteolysis is an intramolecular cleavage. Mol. Cell Neurosci., 29, 65-73.
27. 1-42-associated free radical induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr. Med. Chem., 10, 2651-2659.
28. Cacabelos, R., Alvarez, X.A., Fernandez-Novoa, L., Franco, A., Mangues, R., Pellicer, A., Nishimura, T. (1994) Brain interleukin-1 β in Alzheimer's disease and vascular dementia. Methods Find. Exp. Clin. Pharmacol., 16, 141-151.
29. Carette, B., Poulain, P., Delacourte, A. (1993) Electrophysiological effects of 25-35 amyloid-β-protein on guinea-pig lateral septal neurons. Neurosci. Lett., 151, 111-114.
30. Chapman, P.F., White, G.L., Jones, M.W., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V., Hyman, B.T., Younkin, S.G., Hsiao, K.K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci., 2, 271-276.
31. Chauhan, N.B., Siegel, G.J. (2002) Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody. J. Neurosci. Res., 69, 10-23.
32. Chen, Q.S., Kagan, B.L., Hirakura, Y., Xie, C.W. (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. J. Neurosci. Res., 60, 65-72.
33. Chen, Q.S., Wei, W.Z., Shimahara, T., Xie, C.W. (2002) Alzheimer amyloid β-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem., 77, 354-371.
34. Chin, J., Palop, J.J., Yu, G.Q., Kojima, N., Masliah, E., Mucke, L. (2004) Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J. Neurosci., 24, 4692-4697.
35. Chromy, B.A., Nowak, R.J., Lambert, M.P., Viola, K.L., Chang, L., Velasco, P.T., Jones, B.W., Fernández, S.J., Lacor, P.N., Horowitz, P., Finch, C.E., Krafft, G.A. (2003) Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry, 42, 12749-12760.
36. + channels in rat microglia. Neurosci. Lett., 300, 67-70.
37. Cleary, J.P., Walsh, D.M., Hofmeister, J.J., Shankar, G.M., Kuskowski, M.A., Selkoe, D.J., Ashe, K.H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci., 8, 79-84.
38. Cole, G.M., Yang, F., Chen, P.P., Frautschy, S.A., Hsiao, K. (1999) Caspase activation in dystrophic neurites in Alzheimer's disease and aged HuAPPsw transgenic mice. In: Iqbal, K., Swaab, D.F., Winbland, B., Wisniewski, H.M., Eds., Alzheimer's disease and related disorders: etiology, pathogenesis and therapeutics. New York: Wiley & Sons. pp. 363-369.
39. Cotman, C.W., Pike, C.J., Copan, A. (1992) β-amyloid neurotoxicity: A discussion on in vitro findings. Neurobiol. Aging, 13, 587-590.
40. Cullen, W.K., Suh, Y.H., Anwyl, R., Rowan, M.J. (1997) Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. Neuroreport, 8, 3213-3217.
41. Cullen, W.K., Wu, J., Anwyl, R., Rowan, M.J. (1996) β-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. Neuroreport, 20, 87-92.
42. Cummings, B.J., Cotman, C.W. (1995) Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet, 346, 1524-1528.
43. Cummings, B.J., Pike, C.J., Shankle, R., Cotman, C.W. (1996) β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging, 17, 921-933.
44. Davies, C.A., Mann, D.M., Sumpter, P.Q., Yates, P.O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci., 78, 151-164.
45. Davis, J.N., Chisholm, J.C. (1997) The 'amyloid cascade hypothesis' of AD: decoy or real McCoy? Trends Neurosci., 20, 558-559.
46. DeKosky, S.T., Scheff, S.W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol., 27, 457-464.
47. DeKosky, S.T., Scheff, S.W., Styren, S.D. (1996) Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration, 5, 417-421.
48. DeMattos, R.B., Bales, K.R., Cummins, D.J., Dodart, J.C., Paul, S.M., Holtzman, D.M. (2001) Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 98, 8850-8855.
49. Dewachter, I., Reverse, D., Caluwaerts, N., Ris, L., Kuiperi, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., Moechars, D., Mercken, M., Godaux, E., Van Leuven, F. (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I) transgenic mice. J. Neurosci., 22, 3445-3453.
50. Dickson, D.W., Crystal, H.A., Bevona, C., Honer, W., Vincent, I., Davies, P. (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging, 16, 285-298.
51. Dineley, K.T., Westerman, M., Bui, D., Bell, K., Ashe, K.H., Sweatt, J.D. (2001) β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α-7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci., 21, 4125-4133.
52. Du, Z.Y., Li, X.Y. (1999) Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int. J. Immunopharmacol., 21, 219-225.
53. Dudai, Y. (2002) Molecular bases of long-term memories: a question of persistence. Curr. Opin. Neurobiol., 12, 211-216.
54. Echeverria, V., Ducatenzeiler, A., Dowd, E., Jaén, J., Grant, S.M., ZIF, M., Wandosell, F., Avila, J., Grimm, H., Dunnett, S.B., Hartmann, T., Alhonen, L., Cuello, A.C. (2004) Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience, 129, 583-592.
55. Ekinci, F.J., Malik, K.U., Shea, T.B. (1999) Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. MAP kinase mediates β-amyloid-induced neurodegeneration. J. Biol. Chem., 274, 30322-30327.
56. Etcheberrigaray, E., Gibson, G.E., Alkon, D.L. (1994) Molecular mechanisms of memory and the pathophysiology of Alzheimer's disease. Ann. N. Y. Acad. Sci., 747, 245-255.
57. Fassbender, K., Stroick, M., Bertsch, T., Ragoschke, A., Kuehl, S., Walter, S., Walter, J., Brechtel, K., Muehlhauser, F., Von Bergmann, K., Lutjohann, D. (2002) Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology, 59, 1257-1258.
58. Fastbom, J., Forsell, Y., Winblad, B. (1998). Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis. Assoc. Disord., 12, 14-17.
59. Fitzjohn, S.M., Morton, R.A., Kuenzi, F., Rosahl, T.W., Shearman, M., Lewis, H., Smith, D., Reynolds, D.S., Davies, C.H., Collingridge, G.L., Seabrook, G.R. (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci., 21, 4691-4698.
60. Fluhrer, R., Capell, A., Westmeyer, G., Willem, M., Hartung, B., Condron, M.M., Teplow, D.B., Haass, C., Walter, J. (2002) A non-amyloidogenic function of BACE-2 in secretory pathway. J. Neurochem., 81, 1011-1020.
61. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., Parks, A.L., Xu, W., Li, J., Gurney, M., Myers, R.L., Himes, C.S., Hiebsch, R., Ruble, C., Nye, J.S., Curtis, D. (2002) aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev. Cell., 3, 85-97.
62. Fraser, S.P., Sub, Y.H., Chong, Y.H., Djamgoz, M.B. (1996) Membrane currents induced in Xenopus oocytes by the C-terminal fragment of the β-amyloid precursor protein. J. Neurochem., 66, 2034-2040.
63. Fraser, S.P., Suh, Y.H., Djamgoz, M.B. (1997) Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci., 20, 67-72.
64. Freir, D.B., Holscher, C., Herron, C.E. (2001) Blockade of long-term potentiation by β-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol., 85, 708-713.
65. Fu, W., Luo, H., Parthasarathy, S., Mattson, M.P. (1998) Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis., 5, 229-243.
66. Giacchino, J., Criado, J.R., Games, D., Henriksen, S. (2000) In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res., 876, 185-190.
67. Glenner, G.G., Wong C.W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun., 122, 1131-1135.
68. Goldgaber, D., Lerman, M.I., McBridge, O.W., Saffiotti, V., Gadusek, D.C. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science, 235, 877-880.
69. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E., Hyman, B.T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., 41, 17-24.
70. Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A., Klein, W.L. (2003) Alzheimer's disease-affected brain: presence of oligomeric A ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A., 100, 10417-10422.
71. Grassi, F., Palma, E., Tonini, R., Amici, M., Ballivet, M., Eusebi, F. (2003) Amyloid β1-42 peptide alters the gating of human and mouse α-bungarotoxin-sensitive nicotinic receptors. J. Physiol., 547, 147-157.
72. 2+ channels in PC12 cells via increased amyloid β peptide formation and reactive oxygen species generation. J. Physiol., 541, 1013-1023.
73. Greenfield, J.P., Tsai, J., Gouras, G.K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S.S., Greengard, P., Xu, H. (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A., 96, 742-747.
74. Guzowski, J.F., Lyford, G.L., Stevenson, G.D., Houston, F.P., McGaugh, J.L. (2002) Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches. Hippocampus, 12, 86-104.
75. Hardy, J., Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci., 12, 383-388.
76. Harper, J.D., Lansbury, P.T. Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem., 66, 385-407.
77. Hartley, D.M., Walsh, D.M., Ye, C.P., Diehl, T., Vasquez, S., Vassilev, P.M., Teplow, D.B., Selkoe, D.J. (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci., 19, 8876-8884.
78. Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A., Evans, D.A. (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol., 60, 1119-1122.
79. Honer, W.G., Dickson, D.W., Gleeson, J., Davies, P. (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging, 13, 375-382.
80. Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A.K., Zhang, X.C., Tang, J. (2000) Structure of the protease domain of memapsin 2 (-secretase) complexed with inhibitor. Science, 290, 150-153.
81. Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A., Mucke, L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A., 96, 3228-3233.
82. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 274, 99-102.
83. Itoh, A., Akaike, T., Sokabe, M., Nitta, A., Iida, R., Olariu, A., Yamada, K., Nabeshima, T. (1999) Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol., 382, 167-175.
84. Jarrett, J.T., Berger, E.P., Lansbury, P.T. Jr. (1993) The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry, 32, 4693-7.
85. Jhamandas, J.H., Cho, C., Jassar, B., Harris, K., MacTavish, D., Easaw, J. (2001) Cellular mechanisms for amyloid β-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol., 86, 1312-1320.
86. Kagan, B.L., Azimov, R., Azimova, R. (2004) Amyloid peptide channels. J. Membr. Biol., 202, 1-10.
87. Kagan, B.L., Hirakura, Y., Azimov, R., Azimova, R., Lin, M.C. (2002) The channel hypothesis of Alzheimer's disease: current status. Peptides, 23, 1311-1315.
88. Kalaria, R.N. (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging, 21, 321-330.
89. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., Malinow, R. (2003) APP processing and synaptic function. Neuron, 37, 925-937.
90. Kao, S.C., Krichevsky, A.M., Kosik, K.S., Tsai, L.H. (2004) BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem., 279, 1942-9.
91. Kar, S., Issa, A.M., Seto, D., Auld, D.S., Collier, B., Quirino, R.J., (1998) Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem., 70, 2179-2187.
92. Kar, S., Slowikowski, S.P., Westaway, D., Mount, H.T. (2004) Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci., 29, 427-441.
93. 2+-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys. J., 73, 67-75.
94. Keller, J.N., Pang, Z., Geddes, J.W., Begley, J.G., Germeyer, A., Waeg, G., Mattson, M.P. (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem., 69, 273-284.
95. Kim, H.J., Suh, Y.H., Lee, M.H., Ryu, P.D. (1999) Cation selective channels formed by a C-terminal fragment of β-amyloid precursor protein. Neuroreport, 10, 1427-1431.
96. Kim, J.H., Anwyl, R., Suh, Y.H., Djamgoz, M.B., Rowan, M.J. (2001) Use-dependent effects of amyloidogenic fragments of β-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci., 21, 1327-1333.
97. Kirschner, D.A., Abraham, C., Selkoe, D.J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc. Natl. Acad. Sci. U.S.A., 83, 503-507.
98. Kirschner, D.A., Inouye, H., Duffy, L.K., Sinclair, A., Lind, M., Selkoe, D.J. (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A., 84, 6953-6957.
99. 1-42 into globular neurotoxins. Biochemistry, 42, 12749-12760.
100. Knowles, R.B., Wyart, C., Buldyrev, S.V., Cruz, L., Urbanc, B., Hasselmo, M.E., Stanley, H.E., Hyman, B. (1999) Plaque-induced neurite abnormalities: implication for disruption of neural networks in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 96, 5274-5279.
101. Kokubo, H., Kayed, R., Glabe, C.G., Saido, T.C., Iwata, N., Helms, J.B., Yamaguchi, H. (2005) Oligomeric proteins ultrastructurally localize to cell processes, especially to axon terminals with higher density, but not to lipid rafts in Tg2576 mouse brain. Brain Res., 1045, 224-228.
102. Kokubo, H., Kayed, R., Glabe, C.G., Yamaguchi, H. (2005) Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res., 1031, 222-228.
103. Kojro, E., Gimpl, G., Lammich, S., Marz, W., Fahrenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A., 98, 5815-5820.
104. Kornhauser, J.M., Greenberg, M.E. (1997) A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron, 18, 839-842.
105. Koudinov, A.R., Berezov, T.T. (2004) Alzheimer's amyloid-β (A beta) is an essential synaptic protein, not neurotoxic junk. Acta Neurobiol. Exp., 64, 71-79.
106. Kuo, Y.M., Emmerling, M.R., Vigo-Pelfrey, C., Kasunic, T.C., Kirkpatrick, J.B., Murdoch, G.H., Ball, M.J., Roher, A.E. (1996) Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem., 271, 4077-4081.
107. Lacor, P.N., Buniel, M.C., Chang, L., Fernandez, S.J., Gong, Y., Viola, K.L., Lambert, M.P., Velasco, P.T., Bigio, E.H., Finch, C.E., Krafft, G.A., Klein, W.L. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci., 24, 10191-10200.
108. Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhang, C., Finch, C.E., Krafft, G.A., Klein, W.L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A., 95, 6448-6453.
109. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., Fabrenholz, F. (1999) Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A., 96, 3922-3927.
110. Larson, J., Lynch, G., Games, D., Seubert, P. (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res., 840, 23-35.
111. Lazarov, O., Robinson, J., Tang, Y.P., Hairston, I.S., Korade-Mimics, Z., Lee, V.M., Hersh, L.B., Sapolsky, R.M., Mirnics, K., Sisodia, S.S. (2005) Environmental enrichment reduces AΒ levels and amyloid deposition in transgenic mice. Cell, 120, 701-13.
112. LeVine, H. 3rd. (2004) Alzheimer's β-peptide oligomer formation at physiologic concentrations. Anal. Biochem., 335, 81-90.
113. Li, Y.M., Xu, M., Lai, M.T., Huang, Q., Castro, J.L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J.G., Register, R.B., Sardana, M.K., Shearman, M.S., Smith, A.L., Shi, X.P., Yin, K.C., Shafer, J.A., Gardell, S.J. (2000) Photoactivated γ secretase inhibitors directed to the active site covalently label presenilin 1. Nature, 405, 689-94.
114. Li, W.Y., Butler, J.P., Hale, J.E., McClure, D.B., Little, S.P., Czilli, D.L., Simmons, L.K. (2000) Suppression of an amyloid β peptide-mediated calcium channel response by a secreted beta-amyloid precursor protein. Neuroscience, 95, 1-4.
115. Lin, H., Bhatia, R., Lal, R. (2001) Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J., 15, 2433-2444.
116. Lomo, T. (2003) The discovery of long-term potentiation. Philos. Trans. R. Soc. Land., B, Biol. Sci., 358, 617-620.
117. Lorenzo, A., Yankner, B.A. (1994) β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A., 91, 12243-12247.
118. Lue, L.F., Kuo, Y.M., Roher, A.E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J.H., Rydel, R.E., Rogers, J. (1999) Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol., 155, 853-862.
119. Luth, H.J., Apelt, J., Ihunwo, A.O., Arendt, T., Schliebs, R. (2003) Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res., 977, 16-22.
120. 1-40 in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1β. J. Biol. Chem., 275, 4713-4718.
121. Mark, R.J., Pang, Z., Geddes, J.W., Uchida, K., Mattson, M.P. (1997) Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci., 17, 1046-1054.
122. Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L.A., McKeel, D.W. Jr., Morris, J.C. (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology, 56, 127-129.
123. Masliah, E., Terry, R.D., Alford, M., De Teresa, R., Hansen, L.A. (1991) Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am. J. Pathol., 138, 235-246.
124. Masliah, E., Terry, R.D., Mallory, M., Alford, M., Hansen, L.A. (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am. J. Pathol., 137, 1293-1297.
125. Masters, C.L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R.N., Beyreuther, K. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMO J., 4, 2757-2763.
126. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R.E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci., 12, 376-389.
127. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., Masters C.L. (1999) Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol, 46, 860-866.
128. Micelli, S., Meleleo, D., Picciarelli V., Gallucci, E. (2004) Effect of sterols on β-amyloid peptide (AβP1-40) channel formation and their properties in planar lipid membranes. Biophys. J., 86, 2231-2237.
129. Merz, P.A., Wisniewski, H.M., Somerville, R.A., Bobin, S.A., Masters, C.L., Iqbal, K. (1983) Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. (Berl), 60, 113-24.
130. Middei, S., Geracitano, R., Caprioli, A., Mercuri, N., Ammassari-Teule, M. (2004) Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. Learn. Mem., 11, 447-452.
131. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C.V., Checler, F., Godaux, E., Cordell, B., Van Neuven, F. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem., 274, 6483-6492.
132. Moolman, D.L., Vitolo, O.V., Vonsattel, J-P.G., Shelanski, M.L. (2004) Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol., 33, 377-387.
133. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. (2000) High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci., 20, 4050-4058.
134. Mungarro-Menchaca, X., Ferrera, P., Morán, J., Arias, C. (2002) β-amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J. Neurosci. Res., 68, 89-96.
135. Naslund, J., Haroutunian, V., Mohs, R., Davis, K.L., Davies, P., Greengard, P., Buxbaum, J.D. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAAM, 283, 1571-1577.
136. Nitsch, R.M., Farber, S.A., Growdon, J.H., Wurtman, R.J. (1993) Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. U.S.A., 90, 5191-5193.
137. Parent, A., Linden, D.J., Sisodia, S.S., Borchelt, D.R. (1999) Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis., 6, 56-62.
138. Parvathy, S., Hussain, I., Karran, E.H., Turner, A.J., Hooper, N.M. (1998) Alzheimer's amyloid precursor protein β-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry, 37, 1680-1685.
139. Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., Boyce, R.W., Nelson, N., Kozlosky, C.J., Wolfson, M.F., Rauch, C.T., Cerretti, D.P., Paxton, R.J., March, C.J., Black, R.A. (1998) An essential role for ectodomain shedding in mammalian development. Science, 282, 1281-1284.
140. Petit, A., Bihel, F., Alves, da Costa, C., Pourquie, O., Checler, F., Kraus, J.L. (2001) New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nat. Cell Biol., 3, 507-511.
141. Pettit, D.L., Shao, Z., Yakel, J.L. (2001) β-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci., 21, RC120.
142. Pike, C.J., Walencewicz, A.J., Glabe, C.G., Cotman, C.W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res., 563, 311-314.
143. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., Cotman, C.W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci., 13, 1676-1687.
144. Price, D.L., Koliatsos, V.E., Sisodia, S.S., Koo, E.H., Martin, L.J., Walker, L.C., Appelgate, M.D., Cork, L.C. (1991) Amyloid-related proteins and nerve growth factor in Alzheimer's disease and animal models. Clin. Neuropharmacol., 14 Suppl 1:S9-14.
145. Price, D.L., Sisodia, S.S. (1998) Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci., 21, 479-505.
146. Poirier, J. (2005) Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol. Aging, 26, 355-361.
147. Puzzo, D., Vitolo, O., Trinchese, F., Jacob, J.P., Palmeri, A., Arancio, O. (2005) Amyloid-β peptide inhibits activation of the nitric oxide/ cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J. Neurosci., 25, 6887-6897.
148. Ramirez, J.M., Tryba, A.K., Pena, F. (2004) Pacemaker neurons and neuronal networks: an integrative view. Curr. Opin. Neurobiol., 14, 665-674.
149. 2+ channel currents in primary cultures of rat cortical neurones by amyloid β protein (1-40) is dependent on solubility status. Brain Res., 956, 254-261.
150. + channel currents in primary cultures of rat cerebellar granule and cortical neurons. J. Neurochem., 79, 699-712.
151. Raymond, C.R., Ireland, D.R., Abraham, W.C. (2003) NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus. Brain Res., 968, 263-272.
152. Roder, S., Danober, L., Pozza, M.F., Lingenhoehl, K., Wiederhold, K.H., Olpe, H.R. (2003) Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice. Neuroscience, 120, 705-720.
153. Roher, A.E., Chaney, M.O., Kuo, Y.M., Webster, S.D., Stine, W.B., Haverkamp, L.J., Woods, A.S., Cotter, R.J., Tuohy, J.M., Krafft, G.A., Bonnell, B.S., Emmerling, M.R. (1996) Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem., 271, 20631-20635.
154. Rovira, C., Arbez, N., Mariani, J. (2002) Aβ(25-35) and Aβ(1-40) act on different calcium channels in CA1 hippocampal neurons. Biochem. Biophys. Res. Commun., 296, 1317-1321.
155. Saleshando, G., O'Connor, J.J. (2000) SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett., 288, 119-122.
156. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K, Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., Seubert, P. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173-177.
157. Scragg, J.L., Fearon, I.M., Boyle, J.P., Ball, S.G., Varadi, G., Peers, C. (2005) Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J., 19, 150-152.
158. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498.
159. Selkoe, D.J. (2003) Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman. Neurochem. Res., 28, 1705-1713.
160. Serpell, L.C., Smith, J.M. (2000) Direct visualisation of the β-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol., 299, 225-231.
161. Shoji, M., Golde, T.E, Ghiso, J., Cheung, T.T., Estus, S., Shaffer, L.M., Cai, X.D., McKay, D.M., Tintner, R., Frangione, B., Younkin, S. G. (1992) Production of the Alzheimer amyloid β-protein by normal proteolytic processing. Science, 258, 126-129.
162. Silei, V., Fabrizi, C., Venturini, G., Salmona, M., Bugiani, O., Tagliavini, F., Lauro, G.M. (1999) Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res., 818, 168-170.
163. Small, D.H., Mok, S.S., Bornstein, J.C. (2001) Alzheimer's disease and Aβ toxicity: From top to bottom. Nat. Rev. Neurosci., 2, 595-598.
164. Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K., Greengard, P. (2005) Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci., 8, 1051-1058.
165. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., Hyman B.T. (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci., 25, 7278-7287.
166. Stephan, A., Laroche, S., Davis, S. (2001) Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci., 21, 5703-5714.
167. Stern, E.A., Bacskai, B.J., Hickey, G.A., Attenello, F.J., Lombardo, J.A., Hyman, B.T. (2004) Cortical synaptic integration in vivo is disrupted by amyloid-β plaques. J. Neurosci., 24, 4535-4540.
168. Sun, M.K., Alkon, D.L. (2002) Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by β-amyloid(25-35). J. Neurophysiol., 87, 2441-2449.
169. Sweatt, J.D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem., 6, 1-10.
170. Sze, C.I., Troncoso, J.C., Kawas, C., Mouton, P., Price, D.L., Martin, L.J. (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol., 56, 933-944.
171. Szegedi, V., Juhasz, G., Budai, D., Penke, B. (2005) Divergent effects of Aβ1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res., 1062, 120-126.
172. Tanzi, R.E., McClatchey, A.I., Lamperti, E.D., Villa-Komaroff, L., Gusella, J.F., Neve, R.L. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature, 331, 528-530.
173. Tanzi, R.E., Gusella, J.F., Watkins, P.C., Bruns, G.A.B., St. George-Hyslop, P.H., Van Keuren, M.L., Patterson, D., Pagan, S., Kurnit, D.M., Neve, R.L. (1987) Amyloid β-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 235, 880-884.
174. Terry, R.D. (1996) The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol., 55, 1023-1025.
175. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., Katzman, R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol., 30, 572-580.
176. Tesche, C.D., Karhu, J. (2000) Theta oscillations index human hippocampal activation during a working memory task. Proc. Natl. Acad. Sci. U.S.A., 97, 919-924.
177. 1-42 impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem., 276, 17301-17306.
178. Tsai, J., Grutzendler, J., Duff, K., Gan, W.B. (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci., 7, 1181-1183.
179. Ueda, K., Shinohara, S., Yagami, T., Asakura, K., Kawasaki, K. (1997) Amyloid β protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J. Neurochem., 68, 265-271.
180. Vassar, R., Bennett, B.D., Babu-Khan, S., Khan, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jorosinski, M.A., Biere, A.L., Curran, E., Burguess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., Citron, M. (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286, 735-741.
181. Vigo-Pelfrey, C., Lee, D., Keim, P., Leiberburg, I., Schenk, D.B. (1993) Characterization of b-amyloid peptide from human cerebrospinal fluid. J. Neurochem., 61, 1965-1968.
182. Vitolo, O.V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., Shelanski, M. (2002) Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U.S.A., 99, 13217-13221.
183. Walsh, D.M., Hartley, D.M., Kusumoto, Y., Fezoui, Y., Condron, M.M., Lomakin, A., Benedek, G.B., Selkoe, D.J., Teplow, D.B. (1999) Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem., 274, 25945-25952.
184. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535-539.
185. Walsh, D.M., Selkoe, D.J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 44, 181-193.
186. Walsh, D.M., Townsend, M., Podlisny, M.B., Shankar, G.M., Fadeeva, J.V., Agnaf, O.E., Hartley, D.M., Selkoe, D.J. (2005) Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci., 25, 2455-2462.
187. Wang, H.W., Pasternak, J.F., Kuo, H., Ristic, H., Lambert, M.P., Chromy, B., Viola, K.L., Klein, W.L., Stine, W.B., Krafft, G.A., Trommer, B.L. (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res., 924, 133-140.
188. Wang, Q., Walsh, D.M., Rowan, M.J., Selkoe, D.J., Anwyl, R. (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci., 24, 3370-3378.
189. Whalen, B.M., Selkoe, D.J., Hartley, D.M. (2005) Small nonfibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration. Neurobiol. Dis., 20, 254-266.
190. Weggen, S., Eriksen, J.L., Das, P., Sagi, S.A., Wang, R., Pietrzik, C.U., Findlay, K.A., Smith, T.E., Murphy, M.P., Bulter, T., Kang, D.E., Marquez-Sterling, N., Golde, T.E., Koo, E.H. (2001) A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature, 414, 212-216.
191. Wen, C., Metzstein, M.M., Greenwald, I. (1997) SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development, 124, 4759-4767.
192. Winblad, B., Poritis, N. (1999) Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int. J. Geriatr. Psychiatry, 14, 135-146.
193. Wu, C.C., Chawla, F., Games, D., Rydel, R.E., Freedman, S., Schenk, D., Young, W.G., Morrison, J.H., Bloom, F.E. (2004) Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses. Proc. Natl. Acad. Sci. U.S.A., 101, 7141-7146.
194. Wu, J., Anwyl, R., Rowan, M.J. (1995a) β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport, 6, 2409-2413.
195. Wu, J., Anwyl, R., Rowan, M.J. (1995b) β-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol., 284, R1-3.
196. Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Stratman, N.C., Mathews, W.R., Buhl, A.E., Carter, D.B., Tomasselli, A.G., Parodi, L.A., Heinrikson, R.L., Gurney, M.E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature, 402, 533-537.
197. Yankner, B.A., Duffy, L.K., and Kirschner, D.A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science, 250, 279-282.
198. Yao, P.J., Zhu, M., Pyun, E.I., Brooks, A.I., Therianos, S., Meyers, V.E., Coleman, P.D. (2003) Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis., 12, 97-109.
199. Ye, C.P., Selkoe, D.J., Hartley, D.M. (2003) Protofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures. Neurobiol. Dis., 13, 177-190.
200. Ye, L., Qiao, J.T. (1999) Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett., 275, 187-190.
201. Ye, C., Walsh, D.M., Selkoe, D.J., Hartley, D.M. (2004) Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/ channel activation. Neurosci. Lett., 366, 320-325.
202. Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D.S., Holmes, E., Milman, P., Liang, Y., Zhang, D.M., Xu, D.H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R., Farrer, L.S., Sorbi, S., Bruni, A., Fraser, P., St George-Hyslop, P. (2000) Nicastrin modulates presenilin-mediated notch/ glp-1 signal transduction and betaAPP processing. Nature, 407, 48-54.
203. Yu, S.P., Farhangrazi, Z.S., Ying, H.S., Yeh, C.H., Choi, D.W. (1998) Enhancement of outward potassium current may participate in β-amyloid peptide-induced cortical neuronal death. Neurobiol. Dis., 5, 81-88.
204. Yu, S.P., Yeh, C.H., Sensi, S.L., Gwag, B.J., Canzoniero, L.M., Farhangrazi, Z.S., Ying, H.S., Tian, M., Dugan, L.L., Choi, D.W. (1997) Mediation of neuronal apoptosis by enhancement of outward potassium current. Science, 278, 114-117.
205. Zhang, W., Jin, H.W., Wang, X.L. (2004) Effects of presenilins and β-amyloid precursor protein on delayed rectifier potassium channels in cultured rat hippocampal neurons. Acta Pharmacol. Sin., 25, 181-185.
206. Zimmermann, M., Gardoni, F., Marcello, E., Colciaghi, F., Borroni, B., Padovani, A., Cattabeni, F., Di Luca, M. (2004) Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J. Neurochem., 90, 1489-1499.